In this interactive video module, CCO’s expert faculty provide insights on the critical role ID specialists and hepatologists can play in addressing the ongoing opioid use disorder (OUD) epidemic and discuss useful strategies for incorporating OUD screening, patient evaluation, and treatment into HIV/HCV care settings.
Download this slideset to learn more about the integral role infectious disease specialists and hepatologists can play in combatting the opioid use disorder (OUD) epidemic, including essential strategies for integrating OUD screening, evaluation, and treatment into HIV and HCV care settings.
Download this PDF guide outlining key information on identifying and treating opioid use disorder among patients with HIV and or HCV infection.
What can you do in your clinic to ensure all people who use drugs are screened for HCV and are offered treatment if they have HCV infection?
Infectious disease clinicians are well-poised to comanage HIV and opioid use disorder (OUD). Here’s how you can get started on incorporating routine screening and medication treatment for OUD in your practice.
Although it can be challenging, HIV risk counseling is an important component of substance use disorder care. As addiction care providers are considering barriers to these discussions, we need to ask ourselves, if not now, when? Here’s my take on addressing this critical issue.
In parallel with the opioid epidemic, HCV and HIV outbreaks have ravaged through communities with high rates of opioid overdose, placing HCV and HIV clinicians on the frontlines of these colliding epidemics. So, how do we begin to integrate life-saving treatment for OUD into our practices?
Listen to an insightful discussion between infectious disease experts, Christian B. Ramers, MD, MPH, and Sandra Springer, MD, on current evidence supporting the need for integrated addiction and infectious disease care services.
In this downloadable slideset, CCO’s expert faculty reviews important strategies for expanding addiction medicine services to include prevention, screening, diagnosis, and linkage to HCV and HIV care for patients with opioid use disorder.